- Home
- RVPH vs BRLT Comparison
RVPH vs BRLT Comparison
Compare RVPH & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- BRLT
- Stock Information
- Founded
- RVPH 2006
- BRLT 2005
- Country
- RVPH United States
- BRLT United States
- Employees
- RVPH N/A
- BRLT N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- BRLT Consumer Specialties
- Sector
- RVPH Health Care
- BRLT Consumer Discretionary
- Exchange
- RVPH Nasdaq
- BRLT Nasdaq
- Market Cap
- RVPH 26.6M
- BRLT 22.4M
- IPO Year
- RVPH N/A
- BRLT 2021
- Fundamental
- Price
- RVPH $0.47
- BRLT $1.58
- Analyst Decision
- RVPH Strong Buy
- BRLT Hold
- Analyst Count
- RVPH 5
- BRLT 3
- Target Price
- RVPH $9.00
- BRLT $1.80
- AVG Volume (30 Days)
- RVPH 3.4M
- BRLT 55.4K
- Earning Date
- RVPH 08-13-2025
- BRLT 08-07-2025
- Dividend Yield
- RVPH N/A
- BRLT N/A
- EPS Growth
- RVPH N/A
- BRLT N/A
- EPS
- RVPH N/A
- BRLT N/A
- Revenue
- RVPH N/A
- BRLT $418,708,000.00
- Revenue This Year
- RVPH N/A
- BRLT $3.79
- Revenue Next Year
- RVPH N/A
- BRLT $3.85
- P/E Ratio
- RVPH N/A
- BRLT N/A
- Revenue Growth
- RVPH N/A
- BRLT N/A
- 52 Week Low
- RVPH $0.30
- BRLT $1.25
- 52 Week High
- RVPH $4.28
- BRLT $2.68
- Technical
- Relative Strength Index (RSI)
- RVPH 47.70
- BRLT 60.09
- Support Level
- RVPH $0.38
- BRLT $1.35
- Resistance Level
- RVPH $0.45
- BRLT $1.80
- Average True Range (ATR)
- RVPH 0.03
- BRLT 0.11
- MACD
- RVPH 0.02
- BRLT 0.01
- Stochastic Oscillator
- RVPH 93.07
- BRLT 51.11
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.